The trials of the newly developed Nitric Oxide Nasal Spray (NONS) conducted in London showed exceptional results in treating COVID-19. These trials were performed in London on 80 patients and worked exceedingly well.
On Wednesday, this particular information was shared by the associate director of Research and Development at the St Peter‘s Hospital Dr. Isaac John during a lecture organized by the Pakistan Science Foundation (PSF). He is also a senior lecturer at Royal Hallway, University of London.
During the lecture, Mr. Issac said, “the two stages that the spray acts are before a person is infected with Covid-19 and afterward. If used before infection, it reduces the chances of entry and replication of the virus inside the respiratory tract whereas if people already diagnosed with the virus use the spray, it encapsulates the virus and inhibits its replication, ultimately reducing the chances of infection.”
The importance of vaccination was also highlighted by Dr. Issac while talking to the participants about the COVID-19 breath test and NONS treatment.
As a part of the science popularization activity, the lecture was organized by the Pakistan Science Foundation (PSF). At the lecture, a huge audience was present, including researchers and academicians from some renowned Science and Technology Organisations, Quaid-e-Azam University, and NUST (National University of Sciences and Technology).
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is Effective at Preventing COVID-19 after High-Risk Exposure https://t.co/1APtnJ3635— Jess Mystical-G 🌷 (@MeetJess) May 11, 2022
The Chairman of PSF, Professor Dr. Shahid Mahmood Baig put stress on the number of activities of the foundation that are being conducted. This is being done in order to promote the study of Science and research in the country. Shahid underlined the importance of science and technology for the socio-economic development of Pakistan.
With the increase in the cases of the new Omicron sub-variant, this particular development is opening doors of hope for people.